Cookies on this site

We aim to define the molecular rules governing immune receptor recognition of peptide-HLA-I complexes and apply these insights to infectious disease, reproductive immunology and cancer immunotherapy. Our central hypothesis is that immune recognition cannot be fully explained by receptor sequence and HLA genotype alone. The critical missing element is that peptides presented by HLA-I are essential for receptor recognition not just by T cells, but also by cells of the innate immune system. Decoding this peptide-dependent recognition and building predictive frameworks will reveal new biology and present novel therapeutic opportunities.

Our team

Latest publications

T cell competition in multi-neoantigen cancer vaccines.

Journal article

Hoos E. and Sim MJW., (2026), Nature reviews. Immunology, 26

Using peptide-exchange systems to interrogate peptide-specific KIR binding to HLA Class I.

Journal article

Murali TM. et al, (2026), Discovery immunology, 5

Peptide-specific natural killer cell receptors.

Journal article

Sim MJW. et al, (2025), Oxford open immunology, 6

The molecular reach of antibodies crucially underpins their viral neutralisation capacity.

Journal article

Huhn A. et al, (2025), Nature communications, 16

The peptide selectivity model: Interpreting NK cell KIR-HLA-I binding interactions and their associations to human diseases.

Journal article

Sim MJW. and Long EO., (2024), Trends in immunology, 45, 959 - 970

Identification and structural characterization of a mutant KRAS-G12V specific TCR restricted by HLA-A3.

Journal article

Sim MJW. et al, (2024), European journal of immunology, 54